Liu, C., Zhao, Y., Okwan-Duodu, D., Basho, R. and Cui, X. (2020) COVID-19 in Cancer Patients: Risk, Clinical Features, and Management. Cancer Biology & Medicine, 17, 519-527.
https://doi.org/10.20892/j.issn.2095-3941.2020.0289

has been cited by the following article:

• TITLE: Review of the Prognosis Factors of COVID-19 Infection

  AUTHORS: Bruno Besteiro, Daniel Coutinho, Filipa Gomes, Miguel Almeida, Jorge Almeida

  KEYWORDS: COVID-19, SARS-CoV-2, Prognosis, Outcome, Risk Factors

  JOURNAL NAME: Advances in Infectious Diseases, Vol.11 No.2, June 11, 2021

  ABSTRACT: An epidemic of Coronavirus disease 2019 (COVID-19) outbroke in December 2019 in China, Wuhan, which is becoming a Public Health Emergency of International Concern. As this entity has become one of the worst infectious disease outbreaks of recent times, with mortality estimates in general population ranging from 1.4% to 8%, it is crucial to better understand the prognostic factors which can be associated to the outcome of this disease. However, as the pandemic is still unfortunately under progression, there are limited data with regard to the prognostic factors. Hence, this review seeks to gather and provide the existing data of the literature of all the prognosis factors of COVID-19 infection such as older age, obesity, comorbidities, lymphocytopenia, d-dimers elevation, thrombocytopenia, elevated levels of high-sensitivity cardiac troponin, C-reactive protein elevation and imaging features of COVID-19.